Biotest Pharmaceuticals

Boca Raton, United States Founded: 2007 • Age: 19 yrs Acquired By Grifols
Biotherapeutic products for immunology and liver therapy are manufactured.

About Biotest Pharmaceuticals

Biotest Pharmaceuticals is a Healthcare company based in Boca Raton (United States) founded in 2007, and was acquired by Grifols in August 2018. Biotherapeutic products for immunology and liver therapy are manufactured. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Viral. Its legal entity is Biotest Pharmaceuticals Corporation. Its competitors include Moderna, BeiGene and Adaptive Biotechnologies; 3 of its 3 listed competitors have raised funding.

Company details

Biotest Pharmaceuticals, a subsidiary of Biotest AG, was founded in 2007 in Boca Raton, United States. Biotherapeutic products focused on immunology and liver transplant therapy are researched and manufactured by the company. Source plasma is collected, and plasma protein products for Primary Immune Deficiency are developed. Therapies to prevent re-infection of transplanted livers are also pursued, with Hepatitis C Immune Globulin serving as the lead product for HCV-positive patients.

  • Headquarters Boca Raton, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website biotestpharma.com
  • Social LinkedIn Facebook
  • Acquired by Grifols (Aug 2018)
  • Legal Name Biotest Pharmaceuticals Corporation
Key Metrics

Investors in Biotest Pharmaceuticals

Biotest Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Grifols.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Plasma-derived therapies are developed to treat multiple diseases.
1909grifols.comBarcelona, Spain
Premium access

Investor details for Biotest Pharmaceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Biotest Pharmaceuticals

2 dated milestones of Biotest Pharmaceuticals across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Biotest Pharmaceuticals is founded.
  2. Exit Acquired by Grifols.

Competitors of Biotest Pharmaceuticals

Biotest Pharmaceuticals has 3 listed competitors in our database, 3 of them funded. They include Moderna, BeiGene and Adaptive Biotechnologies.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
modernatx.com2010Cambridge, United States$2.78B1,312
mRNA-based therapeutics for diseases including cancer and infections are developed.
beigene.com2010Cambridge, United States$172M1,090
Targeted and immune-oncology drugs for cancer treatment are developed.
adaptivebiotech.com2009Seattle, United States$419.15M609
Clinical diagnostics and drug discovery for immune diseases are provided.
Premium access

Detailed competitors of Biotest Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Biotest Pharmaceuticals

Websites that share an audience with Biotest Pharmaceuticals (biotestpharma.com).

Similar websites

Websites whose visitors overlap most with Biotest Pharmaceuticals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
biotest.com
100%
14.3K#1,466,190View details
altorbioscience.com
83%
View details
biovail.com
74%
View details
flomedcorp.com
flomedcorp.com
74%
–
summitpharma.co.jp
73%
680.7K#1,877,603View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 13 similar websites and full traffic analytics for Biotest Pharmaceuticals

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 13 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Immunology & Cancer Therapeutics

3 companies that operate in the same segment as Biotest Pharmaceuticals (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Targeted and immune-oncology drugs for cancer treatment are developed.
2010Cambridge, Massachusetts, United StatesUSD 172 M
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biotest Pharmaceuticals

Premium access

Complete news archive for Biotest Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biotest Pharmaceuticals

Biotest Pharmaceuticals was founded in 2007.

Biotest Pharmaceuticals is headquartered in Boca Raton, United States. It is registered at Boca Raton, Florida, United States.

Biotest Pharmaceuticals, a subsidiary of Biotest AG, was founded in 2007 in Boca Raton, United States. Biotherapeutic products focused on immunology and liver transplant therapy are researched and manufactured by the company. Source plasma is collected, and plasma protein products for Primary Immune Deficiency are developed. Therapies to prevent re-infection of transplanted livers are also pursued, with Hepatitis C Immune Globulin serving as the lead product for HCV-positive patients.

Biotest Pharmaceuticals's top competitors include Moderna, BeiGene and Adaptive Biotechnologies.

Biotest Pharmaceuticals has 1 investor. Key investors include Grifols.

Biotest Pharmaceuticals operates through Biotest Pharmaceuticals Corporation.

Yes. Biotest Pharmaceuticals was acquired by Grifols in August 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available